Canada Pension Plan Investment Board
MLYS icon

Canada Pension Plan Investment Board’s Mineralys Therapeutics MLYS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
51,400
+21,800
+74% +$639K ﹤0.01% 955
2025
Q4 		$1.07M Buy
+29,600
New +$1.19M ﹤0.01% 1053
2025
Q2 		– Sell
-279,500
Closed -$4.44M – 1420
2025
Q1 		$4.44M Buy
+279,500
New +$3.21M ﹤0.01% 703

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Canada Pension Plan Investment Board's MLYS Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Mineralys Therapeutics (MLYS) stake by 74% in Q1 2026, buying an estimated $639K and bringing the position to 51,400 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #955.

Canada Pension Plan Investment Board first reported a position in MLYS in Q1 2025 and has held it in 3 quarters since. The position peaked at $4.44M in Q1 2025. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Canada Pension Plan Investment Board held 51,400 shares of Mineralys Therapeutics worth $1.39M as of Q1 2026.
  • Canada Pension Plan Investment Board bought 21,800 Mineralys Therapeutics shares in Q1 2026, an estimated $639K.
  • Mineralys Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #955 holding.
  • Canada Pension Plan Investment Board first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Mineralys Therapeutics position peaked at $4.44M in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.